STERLING PHARMACEUTICALS P/L - परिणामों की खोज

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

fenortho capsule

sterling knight pharmaceuticals llc - fenoprofen calcium (unii: 0x2cw1qabj) (fenoprofen - unii:ra33eac7ky) - fenoprofen 200 mg - fenortho is indicated for: - relief of mild to moderate pain in adults. - relief of the signs and symptoms of rheumatoid arthrites. - relief of the signs and symptoms of osteoarthritis. fenortho is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to fenoprofen or any components of the drug product [ see warnings and precautions ( 5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [ see warnings and precautions ( 5.7, 5.8) ] - in the setting of coronary artery bypass graft (cabg) surgery [ see warnings and precautions ( 5.1) ] risk summary use of nsaids, including fenortho, during the thir

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

phenobarbital tablet

sterling-knight pharmaceuticals, llc - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - phenobarbital 97.2 mg - a. sedative b. anticonvulsant – for the treatment of generalized and partial seizures. phenobarbital is contraindicated in patients who are hypersensitive to barbiturates, in patients with a history of manifest or latent porphyria, and in patients with marked impairment of liver function or respiratory disease in which dyspnea or obstruction is evident. controlled substance – phenobarbital is a schedule iv drug. dependence – barbiturates may be habit forming. tolerance, psychological dependence, and physical dependence may occur, especially following prolonged use of high doses of barbiturates. daily administration in excess of 400 mg of pentobarbital or secobarbital for approximately 90 days is likely to produce some degree of physical dependence. a dosage of 600 to 800 mg taken for at least 35 days is sufficient to produce withdrawal seizures. the average daily dose for the barbiturate addict is usually about 1.5 g. as tolerance to barbiturates develops, the amount needed to maintain the sam

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

omnivex tablet

sterling knight pharmaceuticals llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), pyridoxal phosphate anhydrous (unii: f06sge49m6) (pyridoxal phosphate anhydrous - unii:f06sge49m6), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w), nadh (unii: 4j24dq0916) (nadh - unii:4j24dq0916), coenz - ascorbic acid 125 mg - omnivex is an orally administered prescription vitamin formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced folate supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed. omnivex should be administered under the supervision of a licensed medical practitioner.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

prodigen- lactobacillus acidophilus capsule

sterling knight pharmaceuticals llc - lactobacillus acidophilus (unii: 1prr1v42v5) (lactobacillus acidophilus - unii:1prr1v42v5), bifidobacterium animalis lactis (unii: 5307v7xw8i) (bifidobacterium animalis lactis - unii:5307v7xw8i) - prodigen is an orally administered prescription probiotic formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed. prodigen should be administered under the supervision of a licensed medical practitioner.